Favrille
Inc. About
Favrille: Favrille is a biotechnology company dedicated
to research, development and commercialization of targeted immunotherapies for
the treatment of cancer and other diseases of the immune system. The Company's
near term goal is to show that FavId™ (Favrille's patient-specific therapeutic
vaccine for low grade, follicular, B-cell non-Hodgkin's lymphoma (NHL)) is safe,
effective and commercially viable.